157 related articles for article (PubMed ID: 38521447)
1. The successful treatment of mpox with brincidofovir in renal transplant recipients-a report of 2 cases.
Alameer RM; Yamani A; Al-Saud A; Alsobayeg S; Alamro B; Alali A; Hammad E; Shendi AM; Almaghrabi RS
Int J Infect Dis; 2024 Jun; 143():107015. PubMed ID: 38521447
[TBL] [Abstract][Full Text] [Related]
2. Brincidofovir as Salvage Therapy for Adenovirus Disease in Intestinal Transplant Recipients.
Sulejmani N; Nagai S; Safwan M; Rizzari MD; Raoufi M; Abouljoud MS; Ramesh M
Pharmacotherapy; 2018 Apr; 38(4):470-475. PubMed ID: 29457839
[TBL] [Abstract][Full Text] [Related]
3. Brincidofovir for the treatment of human adenovirus infection in pediatric solid organ transplant recipients: A case series.
Londeree J; Winterberg PD; Garro R; George RP; Shin S; Liverman R; Serluco A; Romero R; Yildirim I
Pediatr Transplant; 2020 Nov; 24(7):e13769. PubMed ID: 32558134
[TBL] [Abstract][Full Text] [Related]
4. The use of brincidofovir for the treatment of mixed dsDNA viral infection.
Camargo JF; Morris MI; Abbo LM; Simkins J; Saneeymehri S; Alencar MC; Lekakis LJ; Komanduri KV
J Clin Virol; 2016 Oct; 83():1-4. PubMed ID: 27513204
[TBL] [Abstract][Full Text] [Related]
5. Disseminated adenovirus infection after allogeneic stem cell transplant and the potential role of brincidofovir - Case series and 10 year experience of management in an adult transplant cohort.
Ramsay ID; Attwood C; Irish D; Griffiths PD; Kyriakou C; Lowe DM
J Clin Virol; 2017 Nov; 96():73-79. PubMed ID: 29017084
[TBL] [Abstract][Full Text] [Related]
6. Adenovirus infection in pediatric transplant recipients: are effective antiviral agents coming our way?
Lopez SMC; Michaels MG; Green M
Curr Opin Organ Transplant; 2018 Aug; 23(4):395-399. PubMed ID: 29846196
[TBL] [Abstract][Full Text] [Related]
7. Brincidofovir (CMX-001) for refractory and resistant CMV and HSV infections in immunocompromised cancer patients: A single-center experience.
El-Haddad D; El Chaer F; Vanichanan J; Shah DP; Ariza-Heredia EJ; Mulanovich VE; Gulbis AM; Shpall EJ; Chemaly RF
Antiviral Res; 2016 Oct; 134():58-62. PubMed ID: 27582067
[TBL] [Abstract][Full Text] [Related]
8. Case report: Brincidofovir-induced reversible severe acute kidney injury in 2 solid-organ transplant for treatment of cytomegalovirus infection.
Faure E; Galperine T; Cannesson O; Alain S; Gnemmi V; Goeminne C; Dewilde A; Béné J; Lasri M; Lessore de Sainte Foy C; Lionet A
Medicine (Baltimore); 2016 Nov; 95(44):e5226. PubMed ID: 27858871
[TBL] [Abstract][Full Text] [Related]
9. Therapeutics for treating mpox in humans.
Fox T; Gould S; Princy N; Rowland T; Lutje V; Kuehn R
Cochrane Database Syst Rev; 2023 Mar; 3(3):CD015769. PubMed ID: 36916727
[TBL] [Abstract][Full Text] [Related]
10. Acute kidney injury requiring dialysis secondary to adenovirus nephritis in renal transplant recipient.
Sujeet K; Vasudev B; Desai P; Bellizzi J; Novoa-Takara L; He C; El-Meanawy A
Transpl Infect Dis; 2011 Apr; 13(2):174-7. PubMed ID: 20946204
[TBL] [Abstract][Full Text] [Related]
11. Brincidofovir for polyomavirus-associated nephropathy after allogeneic hematopoietic stem cell transplantation.
Papanicolaou GA; Lee YJ; Young JW; Seshan SV; Boruchov AM; Chittick G; Momméja-Marin H; Glezerman IG
Am J Kidney Dis; 2015 May; 65(5):780-4. PubMed ID: 25600489
[TBL] [Abstract][Full Text] [Related]
12. Monkeypox in a Kidney Transplant Recipient: Case Report and Literature Review.
Alalawi F; Alhadari F; Tobia H; Alhadari A
Exp Clin Transplant; 2023 Nov; 21(11):913-916. PubMed ID: 38140934
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment of disseminated adenovirus infection with cidofovir and intravenous immunoglobulin in an infant following heart transplant.
Serrano RM; Darragh RK; Parent JJ
Cardiol Young; 2018 Jun; 28(6):888-889. PubMed ID: 29690948
[TBL] [Abstract][Full Text] [Related]
14. Brincidofovir treatment of acyclovir-resistant disseminated varicella zoster virus infection in an immunocompromised host.
Mullane KM; Nuss C; Ridgeway J; Prichard MN; Hartline CB; Theusch J; Mommeja-Marin H; Larson RA
Transpl Infect Dis; 2016 Oct; 18(5):785-790. PubMed ID: 27481400
[TBL] [Abstract][Full Text] [Related]
15. Disseminated adenovirus disease in heart transplant recipient presenting with conjunctivitis.
Bruminhent J; Athas DM; Hess BD; Flomenberg P
Transpl Infect Dis; 2015 Feb; 17(1):125-8. PubMed ID: 25571908
[TBL] [Abstract][Full Text] [Related]
16. Cidofovir and brincidofovir reduce the pathology caused by systemic infection with human type 5 adenovirus in immunosuppressed Syrian hamsters, while ribavirin is largely ineffective in this model.
Tollefson AE; Spencer JF; Ying B; Buller RM; Wold WS; Toth K
Antiviral Res; 2014 Dec; 112():38-46. PubMed ID: 25453340
[TBL] [Abstract][Full Text] [Related]
17. Clinical features, treatment, and outcomes of mpox in solid organ transplant recipients: A multicenter case series and literature review.
Higgins E; Ranganath N; Mehkri O; Majeed A; Walker J; Spivack S; Bhaimia E; Benamu E; Hand J; Keswani S; Dunn D; Beam E; Razonable RR
Am J Transplant; 2023 Dec; 23(12):1972-1979. PubMed ID: 37516243
[TBL] [Abstract][Full Text] [Related]
18. Monkeypox: A re-emerging disease.
Kaur N; Dabar J; Bassi P
Indian J Pharmacol; 2024 Mar; 56(2):129-135. PubMed ID: 38687317
[TBL] [Abstract][Full Text] [Related]
19. Disseminated adenovirus infection in renal transplant recipients: the role of cidofovir and intravenous immunoglobulin.
Saquib R; Melton LB; Chandrakantan A; Rice KM; Spak CW; Saad RD; Fenves AZ; Barri YM
Transpl Infect Dis; 2010 Feb; 12(1):77-83. PubMed ID: 19761559
[TBL] [Abstract][Full Text] [Related]
20. Combination therapy with brincidofovir and valganciclovir against species C adenovirus infection in the immunosuppressed Syrian hamster model allows for substantial reduction of dose for both compounds.
Toth K; Tollefson AE; Spencer JF; Ying B; Wold WSM
Antiviral Res; 2017 Oct; 146():121-129. PubMed ID: 28827083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
